LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 43 filers reported holding LUMOS PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,329,000 | – | 37,203 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 90,794 | $210,642 | 0.38% |
| Acuitas Investments, LLC | 141,435 | $328,129 | 0.18% |
| Wealth Advisors of Iowa, LLC | 11,699 | $27,142 | 0.02% |
| Greenwich Wealth Management LLC | 76,341 | $177 | 0.01% |
| Marquette Asset Management, LLC | 25,760 | $59,764 | 0.01% |
| Paladin Advisory Group, LLC | 4,387 | $9,928 | 0.01% |
| Key FInancial Inc | 10,927 | $25,351 | 0.01% |
| Leucadia National | 120,651 | $279,910 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 27,643 | $64,132 | 0.00% |
| Redwood Wealth Management Group, LLC | 500 | $1,160 | 0.00% |